U.S. Markets closed

FDA approves Sarepta's muscular dystrophy drug

The FDA has approved a drug from Sarepta Therapeutics for muscular dystrophy that it had previously rejected. Yahoo Finance’s Ines Ferre joins The First Trade from the floor of the New York Stock Exchange to discuss the latest market action.